Literature DB >> 16788139

Renal vascular endothelial growth factor in neonatal obstructive nephropathy. II. Exogenous VEGF.

Laura E Burt1, Michael S Forbes, Barbara A Thornhill, Susan C Kiley, Jordan J Minor, Robert L Chevalier.   

Abstract

Chronic unilateral ureteral obstruction (UUO) in the neonatal rat causes delayed renal maturation, tubular apoptosis, and interstitial inflammation. Vascular endothelial growth factor (VEGF) acts as a survival factor for tubular cells and reduces renal injury in several models of renal disease. To determine whether exogenous VEGF attenuates renal injury from UUO, rats were subjected within the first 48 h of life to sham operation, partial UUO, or complete UUO. Saline vehicle or VEGF(121) (50 mg/kg) was injected twice daily for 7 days, after which kidneys were harvested for histological study. The density of peritubular capillaries was measured with platelet-endothelial cell adhesion molecule-1 immunostaining, proliferating nuclei were detected by proliferating-cell nuclear antigen staining, apoptosis by the transferase-mediated dUTP nick end-labeling technique, macrophages by ED-1 immunostaining, and collagen by Sirius red staining. Glomerular number and maturation index were also determined in each group. Following chronic complete UUO in the neonatal rat, peritubular capillary density was significantly decreased. Cortical capillary density was further reduced by exogenous VEGF in the partially obstructed kidney. While UUO also decreased glomerular number and delayed glomerular maturation, exogenous VEGF exerted no additional effects. Cellular proliferation and tubular apoptosis increased in proportion to the severity of obstruction, but exogenous VEGF had no additional effects on proliferation, tubular apoptosis, or macrophage infiltration. However, VEGF reduced interstitial apoptosis in the kidney with partial UUO. We conclude that VEGF does not have salutary effects on the renal lesions caused by chronic UUO in the neonatal rat and may actually worsen obstructive nephropathy by aggravating the interstitial lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788139     DOI: 10.1152/ajprenal.00294.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  5 in total

1.  Inducible nitric oxide synthase modulates hydronephrosis following partial or complete unilateral ureteral obstruction in the neonatal mouse.

Authors:  Kee Hwan Yoo; Barbara A Thornhill; Michael S Forbes; Robert L Chevalier
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-04

Review 2.  Congenital ureteropelvic junction obstruction: human disease and animal models.

Authors:  Julie Klein; Julien Gonzalez; Mathieu Miravete; Cécile Caubet; Rana Chaaya; Stéphane Decramer; Flavio Bandin; Jean-Loup Bascands; Bénédicte Buffin-Meyer; Joost P Schanstra
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

Review 3.  Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases.

Authors:  Changxiu Miao; Xiaoyu Zhu; Xuejiao Wei; Mengtuan Long; Lili Jiang; Chenhao Li; Die Jin; Yujun Du
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 4.  Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

Authors:  Yujiro Kida; Bie Nga Tchao; Ikuyo Yamaguchi
Journal:  Pediatr Nephrol       Date:  2013-03-10       Impact factor: 3.714

Review 5.  Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease.

Authors:  Gert Mayer
Journal:  Nephrol Dial Transplant       Date:  2011-02-17       Impact factor: 5.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.